Abstract

In Saudi Arabia, including regions of Riyadh and Al Ahsa, pseudoparticle neutralisation (ppNT) and microneutralisation (MNT) tests detected no antibodies to Middle East Respiratory Syndrome coronavirus (MERS-CoV) in sheep (n= 100), goats (n= 45), cattle (n= 50) and chickens (n= 240). Dromedary camels however, had a high prevalence of MERS-CoV antibodies. Bovine coronavirus (BCoV) infected sera from cattle had no cross-reactivity in MERS-CoV ppNT or MNT, while many dromedary camels’ sera reacted to both BCoV and MERS-CoV. Some nevertheless displayed specific serologic reaction profiles to MERS-CoV.

Highlights

  • Article submitted on 04 December 2013 / published on 12 December 2013 In Saudi Arabia, including regions of Riyadh and Al Ahsa, pseudoparticle neutralisation and microneutralisation (MNT) tests detected no antibodies to Middle East Respiratory Syndrome coronavirus (MERS-CoV) in sheep (n= 100), goats (n= 45), cattle (n= 50) and chickens (n= 240)

  • In a seroepidemiological study of domestic livestock and dromedary camels from Saudi Arabia, we find that only dromedary camels have evidence of seropositivity to Middle East Respiratory Syndrome coronavirus (MERS-CoV), suggesting an infection with a MERS-CoV-like virus

  • Dromedary camels from the central province of Riyadh as well as the eastern province, Al Ahsa, had comparably high levels of seropositivity to MERS-CoV by pseudoparticle neutralisation (ppNT) tests

Read more

Summary

Introduction

Article submitted on 04 December 2013 / published on 12 December 2013 In Saudi Arabia, including regions of Riyadh and Al Ahsa, pseudoparticle neutralisation (ppNT) and microneutralisation (MNT) tests detected no antibodies to Middle East Respiratory Syndrome coronavirus (MERS-CoV) in sheep (n= 100), goats (n= 45), cattle (n= 50) and chickens (n= 240). Bovine coronavirus (BCoV) infected sera from cattle had no cross-reactivity in MERS-CoV ppNT or MNT, while many dromedary camels’ sera reacted to both BCoV and MERS-CoV.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call